Spero Therapeutics Inc (SPRO)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$1.21-0.82%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · SPRO
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||
| Revenues | — | 66.8 | 48.0 | 103.8 | 53.5 | 18.3 | 9.3 | 18.1 | 4.0 | — |
| Total Revenues | — | 66.8 | 48.0 | 103.8 | 53.5 | 18.3 | 9.3 | 18.1 | 4.0 | — |
| Operating Expenses & Income | ||||||||||
| R&D Expenses | 20.5 | 38.5 | 96.8 | 51.4 | 47.6 | 64.5 | 67.0 | 65.8 | 33.9 | 32.9 |
| Operating Income | 6.0 | 6.3 | (73.4) | 21.5 | (42.2) | (88.0) | (79.1) | (63.2) | (42.8) | (41.7) |
| Earnings from Continuing Operations | ||||||||||
| Interest & Investment Income | 1.6 | 2.5 | 4.7 | 3.9 | 1.1 | 0.3 | 0.4 | 1.3 | — | — |
| Other Non-Operating Income / Expenses | 1.6 | 2.5 | 4.8 | 3.9 | (4.2) | (1.8) | 0.8 | 2.3 | — | — |
| Asset Writedown | — | 0.6 | — | 5.3 | 0.6 | 0.0 | — | — | — | — |
| EBT, Incl. Unusual Items | — | 8.8 | (68.6) | 25.4 | (46.4) | (89.8) | (78.3) | (60.9) | (41.7) | (39.9) |
| Income Tax Expense | — | 0.3 | — | 2.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | ||||||||||
| Minority Interest | — | — | — | — | — | — | — | — | (1.1) | (1.1) |
| Net Income | 7.4 | 8.6 | (68.6) | 22.8 | (46.4) | (89.8) | (78.3) | (60.9) | (41.7) | (38.7) |
| Per Share | ||||||||||
| Basic EPS | 0.13 | 0.15 | (1.27) | 0.43 | (1.23) | (2.91) | — | — | — | — |
| Diluted EPS | 0.13 | 0.15 | (1.27) | 0.43 | (1.23) | (2.91) | — | — | — | — |
| Basic Weighted Avg Shares | 58.0 | 56.0 | 54.0 | 52.7 | 37.6 | 30.9 | — | — | — | — |
| Diluted Weighted Avg Shares | 58.0 | 59.0 | 54.0 | 53.0 | 37.6 | 30.9 | — | — | — | — |
| Supplemental | ||||||||||
| EBITDA | — | — | (73.4) | 21.8 | (41.3) | (87.3) | (78.4) | (62.5) | (42.4) | (41.4) |
| EBIT | 6.0 | 6.3 | (73.4) | 21.5 | (42.2) | (88.0) | (79.1) | (63.2) | (42.8) | (41.7) |
| Effective Tax Rate | — | — | — | 10.2% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.